首页 | 本学科首页   官方微博 | 高级检索  
     


Cardiovascular safety signals with dipeptidyl peptidase‐4 inhibitors: A disproportionality analysis among high‐risk patients
Authors:Sheriza N. Baksh  Mara McAdams‐DeMarco  Jodi B. Segal  G. Caleb Alexander
Affiliation:1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;2. Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, USA;3. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;4. Center for Health Services and Outcomes Research, Johns Hopkins University, Baltimore, MD, USA;5. Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA
Abstract:
Keywords:dipeptidyl peptidase‐IV inhibitors  drug‐related side effects and adverse reactions  heart failure  pharmacoepidemiology  pharmacovigilance
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号